Nöropatik Ağrı Uyku Kalitesini Etkiler mi?

Abstract

Objective: We aimed to evaluate the quality of sleep (QoS) in patients with neuropathic pain (NP) and toinvestigate the association between possible QoS impairment and NP characteristics.Materials and Methods: Patients with NP and controls were examined. Age, sex, NP duration, NP cause(central, peripheral, or mixed), and pain intensity (with a Likert-type scale and visual analog scale) were recorded.NP was screened with Douleur Neuropathique 4 questions (DN4), and QoS was evaluated usingthe Pittsburg Sleep Quality Index (PSQI). Mann-Whitney U test and regression analysis were performed toevaluate the data.Results: Seventy patients with NP and 30 age- and sex-matched controls were included. The mean age ofthe patients and controls were 45.04±10.21 years and 39.00±19.23 years, respectively. Significantly higherscores of sleep latency (p=0.002), sleep duration (p=0.003), sleep efficiency (p=0.002), sleep disturbance(p< 0.000), daytime dysfunction (p=0.04), and PSQI total were observed in patients with NP than in controls(p< 0.000). In addition, 80% of patients with NP and 37 % of controls were classified as having poor QoS(p< 0.000). Female sex, pain intensity, and NP duration were found to be factors related to having poor QoSin patients with NP (p=0.026, p=0.006, and p< 0.000, respectively).Conclusion: In our study, 80% of patients with NP had poor QoS regardless of the NP cause. Female sex,pain severity, and NP duration were found to be factors correlated with poor QoS. Treatment strategies thattarget not only NP itself but also better QoS may contribute to the overall success of management.

Özet

Amaç: Bu çalışmanın amacı nöropatik ağrı (NA) tanısı alan hastalarda uyku kalitesini değerlendirmek uyku kalitesindeki bozulma ile NA'nın özellikleri arasındaki olası ilişkileri incelemekti. Gereç ve Yöntem: Bu çalışmaya NA'lı hastalar ve sağlıklı kontroller dahil edildi. Yaş, cinsiyet, NA süresi, NA nedeni (santral, periferik veya mikst) ve ağrı yoğunluğu (görsel analof skala ve Likert tipi skala ile) kaydedildi. NA (Douleur Neuropathique4 (DN4) anketi ile, uyku kalitesi ise Pittsburg uyku kalitesi indeksi (PUKİ) ile değerlendirildi. Mann-Whitney U testi ve regresyon analizi uygulandı. Bulgular: Bu çalışmaya NA'lı 70 hasta (54 kadın, 16 erkek) ile yaş ve cinsiyet olarak benzer 30 kontrol dahil edildi. Hastaların ve kontrollerin ortalama yaşları sırasıyla 45,04±10,21 ve 39,00±19,23 yıl idi. Hastalarda semptom süresi 24,8±18,2 olarak kaydedildi. NA'lı hastalarda sağlıklılara göre PUKİ bileşenlerinden uykuya geç geçiş (p=0,002), uyku süresi (p=0,003), uyku etkinliği (p=0,002), uyku disturbansı (p